{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amlodipine%3A+8+weeks", "query": { "intervention": "Amlodipine: 8 weeks" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 19, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amlodipine%3A+8+weeks&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T08:41:39.215Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00332761", "title": "Caduet in an Untreated Subject Population", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension", "Dyslipidemia" ], "interventions": [ { "name": "Caduet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 220, "start_date": "2006-06", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2021-01-27", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 34, "location_summary": "Jonesboro, Arkansas • Little Rock, Arkansas • Garden Grove, California + 30 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00332761" }, { "nct_id": "NCT00791258", "title": "A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "amlodipine and olmesartan medoxomil tablets", "type": "DRUG" }, { "name": "hydrochlorothiazide tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 999, "start_date": "2008-11", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2019-01-09", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Green Valley, Arizona • Mesa, Arizona + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Green Valley", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Sierra Vista", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00791258" }, { "nct_id": "NCT00825188", "title": "A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Hypertension" ], "interventions": [ { "name": "eplerenone, amlodipine", "type": "DRUG" }, { "name": "eplerenone", "type": "DRUG" }, { "name": "amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Mississippi Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "21 Years to 100 Years" }, "enrollment_count": 10, "start_date": "2009-01", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2018-05-29", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 1, "location_summary": "Jackson, Mississippi", "locations": [ { "city": "Jackson", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT00825188" }, { "nct_id": "NCT01368536", "title": "Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension", "Stage 2 Hypertension", "Diabetes" ], "interventions": [ { "name": "Valturna", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "Chlorthalidone", "type": "DRUG" }, { "name": "Placebo of Valturna Tablet", "type": "DRUG" }, { "name": "Placebo Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 975, "start_date": "2011-05", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2013-03-21", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 95, "location_summary": "Athens, Alabama • Florence, Alabama • Huntsville, Alabama + 78 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01368536" }, { "nct_id": "NCT00860262", "title": "Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "amlodipine", "type": "DRUG" }, { "name": "telmisartan", "type": "DRUG" }, { "name": "telmisartan and amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 858, "start_date": "2009-03", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-20", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 30, "location_summary": "Buena Park, California • Long Beach, California • Roseville, California + 26 more", "locations": [ { "city": "Buena Park", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00860262" }, { "nct_id": "NCT00739973", "title": "Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Aliskiren 150 mg tablet", "type": "DRUG" }, { "name": "Aliskiren 300 mg tablet", "type": "DRUG" }, { "name": "Amlodipine 5 mg capsule", "type": "DRUG" }, { "name": "Amlodipine 10 mg capsule", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 150/5 mg tablet", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 150/10 mg tablet", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 300/5 mg tablet", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 300/10 mg tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2694, "start_date": "2008-09", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2011-06-06", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00739973" }, { "nct_id": "NCT00877929", "title": "Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Telmisartan 80", "type": "DRUG" }, { "name": "Amlodipine 10", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 706, "start_date": "2009-02", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-03-12", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 15, "location_summary": "Long Beach, California • Tustin, California • Fort Lauderdale, Florida + 12 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Pembroke Pines", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00877929" }, { "nct_id": "NCT01996449", "title": "The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Eplerenone", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "Microneurography", "type": "PROCEDURE" }, { "name": "Rhythmic handgrip exercise", "type": "PROCEDURE" }, { "name": "Sustained hand grip", "type": "PROCEDURE" }, { "name": "Forearm blood flow", "type": "PROCEDURE" }, { "name": "Arm cycling exercise", "type": "PROCEDURE" }, { "name": "Cold Pressor test", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2013-07", "completion_date": "2021-04", "has_results": true, "last_update_posted_date": "2022-03-18", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01996449" }, { "nct_id": "NCT00765674", "title": "Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Aliskiren", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "Hydrochlorothiazide (HCTZ)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1191, "start_date": "2008-09", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2011-05-09", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00765674" }, { "nct_id": "NCT00739596", "title": "Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Aliskiren Hydrochlorothiazide (HCTZ): 8 weeks", "type": "DRUG" }, { "name": "Amlodipine: 8 weeks", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 332, "start_date": "2008-07", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2016-10-27", "last_synced_at": "2026-09-27T08:41:39.215Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00739596" } ] }